Author

L. Dwomoh

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cell Biology· 1 Pharmacology & Toxicology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Organism:mouse· 2 Research Focus:cell signaling & trafficking· 1 Research Focus:cell type annotation· 1 Research Focus:development & morphogenesis· 1 Research Focus:differential expression· 1 Research Focus:host-pathogen & immune response· 1 Assay:proteomics· 1

Frequent Co-Authors

A. B. Tobin· 2 shared G. Milligan· 2 shared L. Jenkins· 2 shared S. Marsango· 2 shared A. M. Abdelmalik· 1 shared B. D. Hudson· 1 shared C. Molloy· 1 shared D. Bolognini· 1 shared

Activity by Year

2021-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 37 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCell Biology

A. B. Tobin

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Phosphorylation bar-coding of Free Fatty Acid receptor 2 is generated in a tissue-specific manner

N. Barki, L. Jenkins, S. Marsango, D. Dedeo, D. Bolognini, L. Dwomoh, A. M. Abdelmalik, M. Nilsen, M. Stoffels, S. Schulz, F. Nagel, A. B. Tobin, G. Milligan

The paper demonstrates tissue-specific phosphorylation patterns of FFA2 in response to the same agonist in different tissues using transgenic mice and phospho-specific antibodies.

bioRxiv · Sep 1, 2023Cell Biology

Phosphorylation of the M1 muscarinic acetylcholine receptor mediates protection in neurodegenerative disease

M. Scarpa, C. Molloy, L. Jenkins, G. S. Tejeda, M. Rossi, L. Dwomoh, S. Marsango, Z. Ahmed, G. Milligan, B. D. Hudson, A. B. Tobin, S. J. Bradley

This study shows that phosphorylation and arrestin-dependent signaling of the M1 muscarinic receptor provides neuroprotection in prion disease, suggesting potential for developing safer therapies for neurodegenerative diseases.

bioRxiv · Apr 29, 2021 · PreprintPharmacology & Toxicology